The University Of Pittsburgh School Of Medicine revealed that sepsis is not one disease but many conditions put together. Many treatments have to be considered to treat sepsis. The Journal of the American Medical Association announced these findings and presents them to the American Thoracic Society’s Annual Meeting. They revealed that sepsis is a life-threatening diseases which takes place when human body’s response to fight an infection injures its own organs and tissues.
Christopher Seymour, M.D., M.Sc, Associate Professor of Pitt’s Critical Care Department says, there has been no advancement in treating sepsis over a decade. The last and latest improvement that researchers witnessed is “One fit treatment” for all. However, sepsis patients are different from each other. It needs different treatments because it is a condition with distinctive clinical symptoms.
Clinical Analysis of Sepsis Dr. Seymour and his team used machine learning and algorithm to study distinctive clinical symptoms that were in health records. There were 29 such clinical variables in health record of patients.
The team studied these patients in four categories:
- Alpha – Patients with no organ failure, no findings in laboratory results, and death rate is just 2%. Such patients form 33% of total patients with sepsis.
- Beta- Geriatric patients, they form 27% of the total population with sepsis. They have kidney failure or dysfunction and with chronic illness.
- Gamma- This is similar to Beta. However, with primary pulmonary disorder and inflammation.
- Delta: This is uncommon, however, it comes with liver failure and trauma. This is the most deadly form of sepsis. It results in 32% death rate. These findings again went through thorough analysis and studies with recent international clinical test. They point to different impressive therapies to treat different types of sepsis.